Showing 381-390 of 3329 results for "".
MATVNews: RT002 Data From Revance Abdominoplasty Risks PFD Patch for Tattoo Removal
https://modernaesthetics.com/series/matv-news/matvnews-rt002-data-from-revance-abdominoplasty-risks-pfd-patch-for-tattoo-removal/33391/In this edition of MATV News, from the editors of Modern Aesthetics® magazine, a look at new data for injectable RT002 from Revance and an update on abdominoplasty risks. Plus, Zwivel and CareCredit team up, and a new PFD patch eases tattoo removal. Talk back: HIPAA Security.Letter to the Editor: Physician Autonomy: We Must Respect Ourselves
https://modernaesthetics.com/ma-issues-index/2015-sept-oct/physician-autonomy-we-must-respect-ourselves/34470/MATV News: Zeltiq Introduces CoolMini; Juvederm Ultra XC Approved for Lips
https://modernaesthetics.com/series/matv-news/matv-news-zeltiq-introduces-coolmini-juv-derm-ultra-xc-approved-for-lips/33395/In this edition of MATV News, from the editors of Modern Aesthetics® magazine, Zeltiq introduces CoolMini for submental fat, Juvéderm is approved for lips, and Syneron launches Picoway Resolve. Also in this edition, we discuss HARMONY study results and topical toxins.MATV News: Long-Term Efficacy Results for Bellafill; Clear + Brilliant Pélo Cleared for Hair Removal
https://modernaesthetics.com/series/matv-news/matv-news-long-term-efficacy-results-for-bellafill-clear-brilliant-pelo-cleared-for-hair-removal/33416/In this edition of MATV News, from the editors of Modern Aesthetics® magazine, we review the five-year efficacy results for Suneva's Bellafill and why needle size matters for neurotoxin injections. Also in this edition, FDA approves Solta's Clear + Brilliant Pélo for hair removal, AAFPRS Annual MeetMATV News: FDA Approves Cellfina to Treat Cellulite; miraDry to Launch miraSmooth
https://modernaesthetics.com/series/matv-news/matv-news-fda-approves-cellfina-to-treat-cellulite-miradry-to-launch-mirasmooth/33419/In this edition of MATV News, from the editors of Modern Aesthetics® magazine, we review the FDA's clearance of Cellfina to treat cellulite with no loss of benefit for up to two-years as well as the new indication for miraDry for hair removal and the launch of miraSmooth. Also in this edition, FDA aMATV News: Restylane Lyft FDA Approval; AAFPRS Meeting News
https://modernaesthetics.com/series/matv-news/matv-news-restylane-lyft-fda-approval-aafprs-meeting-news/33424/In this edition of MATV News, from the editors of Modern Aesthetics® magazine, we review the new FDA approval for Galderma's Restylane Lyft for cheek augmentation and get insights about the upcoming AAFPRS meeting. Also in this edition, FDA approvals for BTL Vanquish and CynoSure's SculpSure, ZwivelMATV News: Allergan to Acquire Kythera; VCS Update
https://modernaesthetics.com/series/matv-news/matv-episode-1-20150623/33432/In this premiere edition of MATV News, from the editors of Modern Aesthetics® magazine, we take a look at the Allergan deal to acquire Kythera Biopharmaceuticals and get insights about the Vegas Cosmetic Surgery & Aesthetic Dermatology. Also in this edition, Radiesse gets FDA approval for hands,Experts Weigh In: Where Devices are Headed in Body Rejuvenation and General Aesthetics
https://modernaesthetics.com/ma-issues-index/2013-july-aug/experts-weigh-in-where-devices-are-headed-in-body-rejuvenation-and-general-aesthetics/34744/Employing Technology for More Personalized Care to Aesthetic Patients
https://modernaesthetics.com/ma-issues-index/2013-may-june/employing-technology-for-more-personalized-care-to-aesthetic-patients/34765/Sex, Skin, and the Endocrine Engine
https://modernaesthetics.com/ma-issues-index/september-october-2025/sex-skin-and-the-endocrine-engine/39266/Why aesthetics needs a hormone upgrade